Wipro GE Healthcare Launches AI-Enabled Versana Premier R3 Ultrasound System in India

Wipro GE Healthcare Launches AI-Enabled Versana Premier R3 Ultrasound System

The Versana Premier R3, an extension of the Versana ultrasound range, integrates AI to enhance workflow automation and improve clinical accuracy. Wipro GE Healthcare has introduced Versana Premier R3, an advanced AI-powered ultrasound system designed to enhance clinical efficiency, streamline workflows, and improve diagnostic accuracy. Manufactured at the company's PLI factory in Bengaluru, the launch aligns with the Indian government's 'Make in India' initiative. The company believes that with India's 1.4 billion population and a rising burden of non-communicable diseases (NCDs), there is a growing need for healthcare technologies that facilitate precise diagnosis and reduce administrative workload. The Versana Premier R3, an extension of the Versana ultrasound range, integrates artificial intelligence to enhance workflow automation and improve clinical accuracy. The system is equipped with AI-driven productivity tools, dynamic tissue imaging optimisation, volume calculation assistance, and a self-learning onboarding tool to support skill development among clinicians. Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia, said, "At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalised, preventive, and affordable." "The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of Made in India MedTech, for India and the world." Emphasising the need for AI-driven healthcare solutions, Anup Kumar, business head, Ultrasound, Wipro GE Healthcare, stated that powered by AI, Versana Premier R3 delivers exceptional image clarity and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions. According to a recent PwC report, 57% of healthcare providers in India have adopted AI, surpassing global adoption rates. The Versana Premier R3's 'VisionBoost architecture' and 8-million-channel digital processing contribute to superior image clarity, while compatibility with 23 different probes enables dynamic organ scanning. Wipro GE Healthcare has been a strong proponent of the 'Make in India' initiative for decades. Products manufactured at its PLI factory include the Revolution Aspire CT system and the Optima IGS320 AI-enabled Cath Lab. Earlier this year, the company announced an investment of over INR 8,000 crores in manufacturing output and local R&D over the next five years. Further, AIIMS partnered with Wipro GE Healthcare in December 2024 to advance AI-driven healthcare solutions. With AIIMS offering real-world clinical insights and Wipro GE Healthcare committing a $1 million investment, the collaboration aims to redefine key medical fields like cardiology, oncology, and neurology through intelligent systems and workflow innovations.

Wipro GE Healthcare Launches 'AI Enabled - Made in India' Ultrasound System - Versana Premier R3

Strengthening commitment to Atmanirbhar Bharat, the state-of-the-art ultrasound system will be manufactured in the company's PLI factory in Bengaluru, India. The integration of AI with ultrasound technology aims to help advance clinical efficiency and accuracy and improve patient outcomes. Wipro GE Healthcare Pvt Ltd, a leading global provider of healthcare technologies, today announced the launch of the Versana Premier R3, an advanced AI-enabled ultrasound system designed to enhance clinical efficiency and accuracy, streamline workflows, and improve patient outcomes. Catapulting Government's 'Make in India' vision, the state-of-the-art ultrasound system will be manufactured at Wipro GE Healthcare's PLI factory in Bengaluru. India's 1.4Bn population, and a burgeoning NCD problem, underline the need for advanced technologies to enable precise diagnosis, improve clinical accuracy, and reduce the administrative burden. An extension of the Versana ultrasound range, Versana Premier R3 integrates artificial intelligence and offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The advanced ultrasound system aims to help clinicians deliver more personalized, ubiquitous, and preventive care. Addressing the skill gap, the system will optimize dynamic tissue imaging, assist with volume calculations, and streamline workflows. Its self-learning onboarding tool will empower the clinicians to enhance their skills and adapt to new workflows. Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia said, "At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalized, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of 'Made in India MedTech - for India and the world." Anup Kumar, Business Head, Ultrasound, Wipro GE Healthcare added, "We are very proud to launch the Versana Premier R3, our state-of-the-art our 'Made in India' ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalized, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers exceptional image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions." A recent report by PwC indicates that 57% of healthcare providers in India are using AI, significantly higher than the adoption rates globally. As India embraces the potential of artificial intelligence in healthcare, Versana Premier R3 represents a significant leap in diagnostic capabilities. The product's cutting-edge 'VisionBoost architecture' and 8-million-channel digital processing deliver exceptional image clarity. With compatibility for 23 different probes, the system offers dynamic organ scanning. Wipro GE Healthcare has been pioneering 'Make in India - for India and the world' for decades. Other Made in India products from the company's PLI factory include the Revolution Aspire CT system and Optima IGS320 AI-enabled Cath Lab, among others. Earlier this year, Wipro GE Healthcare also announced an investment of over INR8000 Crores in manufacturing output & local R&D over the next 5 years. About Wipro GE Healthcare Pvt. Ltd. Wipro GE Healthcare Private Limited is a Joint Venture (JV) between GE Precision Healthcare LLC, USA, and Wipro Enterprises Limited, India. Established in 1990, it is one of the most successful and longest-running JVs in the region with operations spread across India, Bangladesh, Sri Lanka, Nepal, Maldives and Bhutan. The company is one of the most premium Medical Technology players in the South Asia region. Wipro GE Healthcare is focused on addressing some of the toughest healthcare challenges - helping lower maternal and infant deaths, enabling early detection of cancer, providing precision-care pathways for heart diseases, and driving better outcomes for trauma patients, among others. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.